SFM

Sphera Funds Management Portfolio holdings

AUM $382M
This Quarter Return
+6.89%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$491M
AUM Growth
+$491M
Cap. Flow
+$65.6M
Cap. Flow %
13.37%
Top 10 Hldgs %
36.88%
Holding
146
New
36
Increased
29
Reduced
18
Closed
21

Top Buys

1
GSK icon
GSK
GSK
$19.4M
2
GILD icon
Gilead Sciences
GILD
$16.3M
3
ALXN
Alexion Pharmaceuticals Inc
ALXN
$12.2M
4
CLVS
Clovis Oncology, Inc.
CLVS
$8.71M
5
TSRO
TESARO, Inc.
TSRO
$7.69M

Top Sells

1
SHPG
Shire pic
SHPG
$24.1M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$7.09M
3
TEVA icon
Teva Pharmaceuticals
TEVA
$5.52M
4
CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
$5.08M
5
NVS icon
Novartis
NVS
$4.39M

Sector Composition

1 Healthcare 79.26%
2 Technology 7.56%
3 Industrials 3.16%
4 Communication Services 2.73%
5 Financials 1.3%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TXMD icon
51
TherapeuticsMD
TXMD
$12.8M
$3.06M 0.52% 580,000 – –
EIGR
52
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.04M 0.52% 385,301 – –
OVID icon
53
Ovid Therapeutics
OVID
$91M
$3.04M 0.52% +305,674 New +$3.04M
BLCM
54
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$2.92M 0.5% 250,000 +50,000 +25% +$584K
BOLD
55
DELISTED
Audentes Therapeutics, Inc
BOLD
$2.87M 0.49% +150,000 New +$2.87M
NBIX icon
56
Neurocrine Biosciences
NBIX
$13.8B
$2.85M 0.48% 62,000 -88,000 -59% -$4.05M
STML
57
DELISTED
Stemline Therapeutics, Inc.
STML
$2.76M 0.47% 300,000 – –
BCLI
58
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$2.76M 0.47% +833,633 New +$2.76M
AXSM icon
59
Axsome Therapeutics
AXSM
$6.05B
$2.76M 0.47% 501,000 +100,000 +25% +$550K
CLSD icon
60
Clearside Biomedical
CLSD
$28.9M
$2.73M 0.46% 300,000 – –
ENDP
61
DELISTED
Endo International plc
ENDP
$2.68M 0.46% +240,000 New +$2.68M
CYTK icon
62
Cytokinetics
CYTK
$4.23B
$2.64M 0.45% 217,990 +65,790 +43% +$796K
GNCA
63
DELISTED
Genocea Biosciences, Inc.
GNCA
$2.56M 0.43% 490,000 -156,273 -24% -$816K
CASC
64
DELISTED
Cascadian Therapeutics, Inc.
CASC
$2.53M 0.43% 681,210 +100,000 +17% +$372K
SNA icon
65
Snap-on
SNA
$17B
$2.5M 0.42% 15,797 – –
LRCX icon
66
Lam Research
LRCX
$127B
$2.39M 0.41% +16,860 New +$2.39M
FSTX
67
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$2.37M 0.4% +175,000 New +$2.37M
ORCL icon
68
Oracle
ORCL
$635B
$2.37M 0.4% +47,250 New +$2.37M
PTLA
69
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.25M 0.38% +40,000 New +$2.25M
NDRM
70
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$2.23M 0.38% +74,500 New +$2.23M
PRTA icon
71
Prothena Corp
PRTA
$441M
$2.17M 0.37% +40,000 New +$2.17M
ALBO
72
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$2.13M 0.36% +103,526 New +$2.13M
DOVA
73
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$2.12M 0.36% +95,000 New +$2.12M
TMO icon
74
Thermo Fisher Scientific
TMO
$186B
$2.04M 0.35% 11,688 +4,775 +69% +$833K
OBSV
75
DELISTED
ObsEva SA Ordinary Shares
OBSV
$1.98M 0.34% 231,497 +20,411 +10% +$174K
1 2
3
4 5